Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 4, 2025Current Pharmaceutical Design

Advancements in Personalized Medicine for Leukemia: Integrating Genetic, Transcriptomic, and Artificial Intelligence Insights

View Full Paper
Ask AI
Bookmark
Share

Authors

RRRamin RaoufiniaUniversity of NeyshaburMAMehdi AlimoradiIslamic Azad University, IsfahanMKMotahhareh KarimoddiniMashhad University of Medical Sciences

Discussion

Loading...

Member takes

Implication

This review highlights how personalized medicine improves leukemia diagnosis and treatment through AI, transcriptomics, and genetic profiling.

Key Points

  • Personalized medicine enhances leukemia treatment, integrating AI and molecular profiling for better outcomes.
  • Advancements include AI-driven methods improving diagnosis and therapeutic strategies in leukemia management.
  • The review covers genetic and transcriptomic insights from RNA sequencing, pivotal for precision medicine applications.
  • Ongoing challenges like genetic heterogeneity and treatment resistance call for integrating emerging technologies.

Cite This Study

Raoufinia et al. (2025) studied this question.

synapsesocial.com/papers/690945348f2297dc13532fb4https://doi.org/10.2174/0113816128402252251005215721
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular Pathogenesis and Evolving Precision Medicine in Leukemia2025
  2. 2Advances in Leukemia detection and classification: A Systematic review of AI and image processing techniques2025 · 8 citations
  3. 3Bytes to blood: Artificial intelligence in leukemia management—A 2025 update.2026
  4. 4Advanced Molecular Techniques for the Diagnosis and Prognosis ofLeukemias2026
  5. 5Artificial intelligence reshaping the paradigm of hematologic malignancy diagnosis and treatment: From static assessment to dynamic precision management2026 · 2 citations